Inventor

PFIZENMAIER KLAUS

DE21 patents

⚠️ This page may combine multiple inventors who share the name “PFIZENMAIER KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PFIZENMAIER KLAUS

UNIV STUTTGART

Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity

Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity

TNFR2 agonists with improved stability

Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof

Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof

huTNFR1 selective antagonists

Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof

PFIZENMAIER KLAUS

Monoclonal antibodies with specific binding against membrane proteins on human cells, and pharmaceutical compositions containing them

Recombinant polypeptides of the members of the TNF ligand family and use thereof

Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor

Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines)

huTNFR1 selective antagonists

ONCOMATRYX BIOPHARMA S L

Antibody-drug conjugates and immunotoxins

Antibody-drug conjugates and immunotoxins

Antibody-drug conjugates and immunotoxins

BIONTECH RNA PHARMACEUTICALS GMBH

Cytokine fusion proteins

Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands

FRAUNHOFER GES FORSCHUNG

Nanoparticles comprising biologically active TNF which is immobilized on the same

KONTERMANN ROLAND

Anti-huTNFR1 antibody and methods of use thereof for treatment

BALIOPHARM AG

Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody

BIONTECH AG

Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)